Back to Search
Start Over
The next decade in structural biology.
- Source :
-
Structure (London, England : 1993) [Structure] 2023 Nov 02; Vol. 31 (11), pp. 1284-1288. - Publication Year :
- 2023
-
Abstract
- As we celebrate the 30 <superscript>th</superscript> anniversary of Structure, we have asked structural biologists about their expectations on how their respective fields are likely to develop in the next ten years in this collection of Voices.<br />Competing Interests: Declaration of interests P.M.S. is a scientific co-founder and shareholder of Septerna Inc. D.W. is a shareholder of Septerna Inc. P.M.S. and D.W. consult for Septerna Inc. P.M.S. and D.W. are co-founders and shareholders in DACRA Therapeutics. P.M.S. and D.W. receive research funding from the following companies: AstraZeneca, Astex Pharmaceuticals, Boehringer Ingelheim, Dimerix, Novo Nordisk, Pfizer, and Septerna Inc.<br /> (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Subjects :
- Molecular Biology trends
Subjects
Details
- Language :
- English
- ISSN :
- 1878-4186
- Volume :
- 31
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Structure (London, England : 1993)
- Publication Type :
- Academic Journal
- Accession number :
- 37922863
- Full Text :
- https://doi.org/10.1016/j.str.2023.10.002